Elisabeth de Vries

Dikutip oleh

	Semua	Sejak 2020
Kutipan	114595	37224
indeks-h	146	74
indeks-i10	886	427

8000

4000

2000

6000

199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025465 523 667 770 873 821 735 879 954 1180 1395 1610 2006 2449 2771 2976 3032 3488 3928 4753 4859 4976 5210 5913 5640 5886 6122 7044 7769 7507 6940 6608 1332

Akses publik

Lihat semua

164 artikel

8 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Marjolijn Lub-de HoogeUniversity Medical Center GroningenEmail yang diverifikasi di umcg.nl
Steven de JongProfessor of Preclinical and Translational Oncology, University Medical Center GroningenEmail yang diverifikasi di umcg.nl
Gietema JAProfessor of Medical Oncology, University Medical Center GroningenEmail yang diverifikasi di umcg.nl
Winette van der GraafProfessor of Personalised Oncology, the Institute of Cancer Research/Royal Marsen, London, UKEmail yang diverifikasi di icr.ac.uk
Geke HospersProfessor of medical oncologyEmail yang diverifikasi di umcg.nl
Sjoukje OostingMedical Oncologist, University Medical Center GroningenEmail yang diverifikasi di umcg.nl
RSN FehrmannUniversity Medical Center GroningenEmail yang diverifikasi di umcg.nl
Annemiek WalenkampEmail yang diverifikasi di umcg.nl
Derk Jan de GrootMD PhD, Medical oncologist, University Medical Center GroningenEmail yang diverifikasi di umcg.nl
Jos KosterinkHoogleraar Hospital and Clinical Pharmacy, UMCG, RUG GroningenEmail yang diverifikasi di umcg.nl
A GlaudemansUniversity Medical Center GroningenEmail yang diverifikasi di umcg.nl
Nathan I. ChernyShaare Zedek Medical CenterEmail yang diverifikasi di netvision.net.il
G J te Meermanemeritus associate professor in mathematical genetics and bioinformatics, researcher geneticsEmail yang diverifikasi di umcg.nl
Lesley SeymourQueens UniversityEmail yang diverifikasi di ctg.queensu.ca
Marcel van VugtProfessor of Molecular Oncology, University of Groningen, University Medical CentreEmail yang diverifikasi di umcg.nl
Marian J.E. MouritsProfessor Gynecologic Oncology, University Medical Center GroningenEmail yang diverifikasi di umcg.nl
HM Boezensearch "Boezen or Marike Boezen''Email yang diverifikasi di umcg.nl
Frederike BenschUniversity Medical Center GroningenEmail yang diverifikasi di umcg.nl
Bert van der VegtUniversity of Groningen, University Medical Center Groningen, Groningen, The NetherlandsEmail yang diverifikasi di umcg.nl
Urania DafniProfessor of Biostatistics, National and Kapodistrian University of Athens, GreeceEmail yang diverifikasi di nurs.uoa.gr

Ikuti

Elisabeth de Vries

Professor of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands

Email yang diverifikasi di umcg.nl


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 365 (9472), 1687-1717, 2005	8010	2005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005	6370	2005
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 … Early Breast Cancer Trialists' Collaborative Group The Lancet 378 (9804), 1707-1716, 2011	4138	2011
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials EBCTC Group The lancet 378 (9793), 771-784, 2011	3988*	2011
Everolimus for advanced pancreatic neuroendocrine tumors JC Yao, MH Shah, T Ito, CL Bohas, EM Wolin, E Van Cutsem, TJ Hobday, ... New England Journal of Medicine 364 (6), 514-523, 2011	3500	2011
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics L Seymour, J Bogaerts, A Perrone, R Ford, LH Schwartz, S Mandrekar, ... The Lancet Oncology 18 (3), e143-e152, 2017	2253	2017
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … P McGale, C Correa, D Cutter, F Duane, M Ewertz, R Gray, G Mannu, ... The Lancet 383 (9935), 2127-35, 2014	2032	2014
RECIST 1.1—Update and clarification: From the RECIST committee LH Schwartz, S Litière, E De Vries, R Ford, S Gwyther, S Mandrekar, ... European journal of cancer 62, 132-137, 2016	1757	2016
20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years H Pan, R Gray, J Braybrooke, C Davies, C Taylor, P McGale, R Peto, ... New England Journal of Medicine 377 (19), 1836-1846, 2017	1711	2017
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015	1414	2015
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo … ME Pavel, JD Hainsworth, E Baudin, M Peeters, D Hörsch, RE Winkler, ... The Lancet 378 (9808), 2005-2012, 2011	1216	2011
Response assessment criteria for brain metastases: proposal from the RANO group NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ... The lancet oncology 16 (6), e270-e278, 2015	1002	2015
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical … NI Cherny, R Sullivan, U Dafni, JM Kerst, A Sobrero, C Zielinski, ... Annals of oncology 26 (8), 1547-1573, 2015	942	2015
Biodistribution of ⁸⁹Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer EC Dijkers, TH Oude Munnink, JG Kosterink, AH Brouwers, PL Jager, ... Clinical Pharmacology & Therapeutics 87 (5), 586-592, 2010	918	2010
Evidence based selection of housekeeping genes HJM de Jonge, RSN Fehrmann, ESJM de Bont, RMW Hofstra, F Gerbens, ... PloS one 2 (9), e898, 2007	875	2007
Overexpression of a M_r 110,000 Vesicular Protein in Non-P-Glycoprotein-mediated Multidrug Resistance RJ Scheper, HJ Broxterman, GL Scheffer, P Kaaijk, WS Dalton, ... Cancer research 53 (7), 1475-1479, 1993	845	1993
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. M Müller, C Meijer, GJ Zaman, P Borst, RJ Scheper, NH Mulder, ... Proceedings of the National Academy of Sciences 91 (26), 13033-13037, 1994	786	1994
Radiolabeled amino acids: basic aspects and clinical applications in oncology PL Jager, W Vaalburg, J Pruim, EGE de Vries, KJ Langen, DA Piers Journal of nuclear medicine 42 (3), 432-445, 2001	773	2001
A review on CXCR4/CXCL12 axis in oncology: no place to hide UM Domanska, RC Kruizinga, WB Nagengast, H Timmer-Bosscha, ... European journal of cancer 49 (1), 219-230, 2013	751	2013
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1353-1361, 2015	706	2015

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama